Skip to content

Patient Controlled Remifentanil Analgesia for Normal Labour

Patient Controlled Remifentanil Analgesia vs. Epidural Analgesia for Normal Labour. A Prospective Randomised Study

Status
Withdrawn
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04541719
Enrollment
0
Registered
2020-09-09
Start date
2017-04-01
Completion date
2018-07-01
Last updated
2020-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Full Term Pregnancy, Labor Pain

Brief summary

Patient controlled remifentanil analgesia might offer comparative overall patient satisfaction and improved quality of analgesia after normal labour with continuous epidural analgesia.

Detailed description

We are aiming to study the effects of patient controlled remifentanil analgesia and epidural analgesia for normal labour in full term parturients on: * Peripartum analgesia * Overall patient's satisfaction * Maternal adverse effects * Neonatal outcomes

Interventions

DRUGPatient-controlled remifentanil analgesia

Patient controlled remifentanil analgesia with a regimen to provide a bolus of 40 μg remifentanil with a lockout interval of 2 min

DRUGEpidural analgesia

Patients will receive continuous epidural analgesia using bupivacaine 0.125% in conjunction with fentanyl 2 ug/ml at a rate of 8-15 ml/hr

Sponsors

Cairo University
CollaboratorOTHER
Alexandria University
CollaboratorOTHER
Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Gestational age \> 36 weeks * American Society of Anesthesiologists physical class I to III

Exclusion criteria

* Allergy to study solution * Contraindications to epidural analgesia * Non consented parturients * Communications barriers. * Intrauterine foetal growth retardation * Foetal distress

Design outcomes

Primary

MeasureTime frameDescription
Overall patient's satisfactionFor 24 hours after labourAs being assesses using 100-mm visual analog score (0: unsatisfied, 100: very satisfied)

Secondary

MeasureTime frameDescription
Neonatal blood pHFor 5 min after birthpH value
Neonatal Apgar score at 1 minFor 5 min after birthAssessed using 5-points Apgar score
Neonatal Apgar score at 5 minFor 5 min after birthAssessed using 5-points Apgar score
Neonatal blood PaO2For 5 min after birthPaO2 value
Neonatal blood PaCO2For 5 min after birthPaCO2 value
Pain Visual Analog Score on movementFor 24 hours after the start of labour painAs being assesses using 10-cm visual analog score (0: no pain, 10: very agonising pain)
Maternal nausea and vomitingFor 24 hours after the start of labour pain(0: no nausea or vomiting, 1: severe nausea, 3: vomiting)
Maternal respiratory depressionFor 24 hours after the start of labour painIf respiratory rate decreases less than 10/min
Pain Visual Analog Score at restFor 24 hours after the start of labour painAs being assesses using 10-cm visual analog score (0: no pain, 10: very agonising pain)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026